GlassScriptPhysician profile
Cathleen D Bentley
NPI 1043383169
$2,637.23
in general payments reported to CMS, 2019-2025
14 companies · $567 in 2025
The $567 reported for 2025 was more than what 97% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $455 · 2022: $472 · 2023: $538 · 2024: $606 · 2025: $567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,710.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,710.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $889.72 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $871.92 | 2021-2025 | Xifaxan, Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $332.49 | 2021-2025 | Entyvio, Gattex |
| Janssen Biotech, INC. | $150.10 | 2022-2023 | Simponi, Simponi Aria, Stelara |
| Lilly USA, LLC | $147.09 | 2024-2025 | Omvoh, Zepbound |
| Regeneron Healthcare Solutions, INC. | $65.49 | 2023-2025 | Dupixent |
| Braintree Laboratories, INC. | $49.69 | 2022-2024 | Suflave |
| Axonics, INC. | $33.73 | 2022-2024 | Axonics |
| Vertex Pharmaceuticals Incorporated | $18.96 | 2024 | |
| Ethicon US, LLC | $17.61 | 2025 | Echelon Circular |
| Celltrion USA INC. | $17.19 | 2025 | Vegzelma |
| Merck Sharp & Dohme LLC | $16.81 | 2023 | Bridion |
| Eagle Pharmaceuticals, INC. | $13.62 | 2023 | |
| Redhill Biopharma INC. | $12.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cathleen Bentley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.